- Home
- APLS vs M Comparison
APLS vs M Comparison
Compare APLS & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLS | M |
|---|---|---|
| Founded | 2009 | 1830 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.8B |
| IPO Year | 2015 | 2002 |
Fundamental Metrics
Financial Performance| Metric | APLS | M |
|---|---|---|
| Price | $40.92 | $20.07 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 21 | 13 |
| Target Price | ★ $33.59 | $20.09 |
| AVG Volume (30 Days) | ★ 8.7M | 5.2M |
| Earning Date | 05-04-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ 112.50 | 12.08 |
| EPS | 0.20 | ★ 2.32 |
| Revenue | $1,003,782,000.00 | ★ $22,621,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.19 | N/A |
| P/E Ratio | $204.53 | ★ $8.74 |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $10.99 |
| 52 Week High | $40.95 | $24.41 |
Technical Indicators
Market Signals| Indicator | APLS | M |
|---|---|---|
| Relative Strength Index (RSI) | 87.30 | 63.42 |
| Support Level | $19.29 | $19.80 |
| Resistance Level | N/A | $21.14 |
| Average True Range (ATR) | 0.11 | 0.60 |
| MACD | -0.32 | 0.23 |
| Stochastic Oscillator | 94.44 | 83.22 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.